Showing results (21-30 of 96) with videos related to
Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|January 4, 2015
Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consortium studyJaime R Merchan, Rui Qin, Henry Pitot, et al.Journal of Gastrointestinal Oncology|June 12, 2019
Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancerManik Amin, Monica Desai, Kathryn Trinkaus, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancerPhilip A Philip, Michelle R Mahoney, Cristine Allmer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Phase II study of erlotinib in patients with advanced biliary cancerPhilip A Philip, Michelle R Mahoney, Cristine Allmer, et al.Clinical Genitourinary Cancer|July 30, 2013
A phase II safety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancerRoberto Pili, Rui Qin, P J Flynn, et al.Cancer Research|May 3, 2003
CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinomaAdam S Kibel, Brian K Suarez, Jay Belani, et al.Cancer|December 20, 2011
Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: results of Cancer and Leukemia Group B (CALGB) 9782J Paul Monk, Susan Halabi, Joel Picus, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583)Eric J Small, Susan Halabi, Nancy A Dawson, et al.Cancer Chemotherapy and Pharmacology|May 23, 2007
A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancerRamesh K Ramanathan, Joel Picus, Haralambos Raftopoulos, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2003
11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapseNobuyuki Oyama, Tom R Miller, Farrokh Dehdashti, et al.Pageof 10